211 related articles for article (PubMed ID: 32381929)
21. Comparison of clinical outcome of hepatic arterial infusion chemotherapy and sorafenib for advanced hepatocellular carcinoma according to macrovascular invasion and transcatheter arterial chemoembolization refractory status.
Kodama K; Kawaoka T; Aikata H; Uchikawa S; Inagaki Y; Hatooka M; Morio K; Nakahara T; Murakami E; Tsuge M; Hiramatsu A; Imamura M; Kawakami Y; Masaki K; Honda Y; Mori N; Takaki S; Tsuji K; Kohno H; Kohno H; Moriya T; Nonaka M; Hyogo H; Aisaka Y; Chayama K
J Gastroenterol Hepatol; 2018 Oct; 33(10):1780-1786. PubMed ID: 29645345
[TBL] [Abstract][Full Text] [Related]
22. The Outcome of Sorafenib Therapy on Unresectable Hepatocellular Carcinoma: Experience of Conversion and Salvage Hepatectomy.
Yoshimoto T; Imura S; Morine Y; Ikemoto T; Arakawa Y; Iwahashi S; Saito YU; Takasu C; Ishikawa D; Teraoku H; Bando Y; Shimada M
Anticancer Res; 2018 Jan; 38(1):501-507. PubMed ID: 29277815
[TBL] [Abstract][Full Text] [Related]
23. [Effect of sorafenib and prophylactic TACE for prevention of postoperative relapse in patients with liver cancer combined with microvascular invasion].
Shen PC; Gao ZQ; Li DY; Tang Z
Zhonghua Gan Zang Bing Za Zhi; 2020 May; 28(5):416-420. PubMed ID: 32536058
[No Abstract] [Full Text] [Related]
24. [The possible role of sorafenib as a part of the multimodal treatment for hepatocellular carcinoma].
Ishiko T; Beppu T; Chikamoto A; Tanaka H; Masuda T; Okabe H; Mima K; Horino K; Takamori H; Nakahara O; Baba H
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2499-501. PubMed ID: 22202426
[TBL] [Abstract][Full Text] [Related]
25. [A case of advanced hepatocellular carcinoma with portal vein invasion successfully treated by sorafenib].
Endo Y; Miyamoto M; Koujima T; Watanabe Y; Kawai T; Toda K; Nobuhisa T; Watanabe T; Matsumoto Y; Watanabe N; Kai K; Sato S
Gan To Kagaku Ryoho; 2012 Jun; 39(6):963-5. PubMed ID: 22705693
[TBL] [Abstract][Full Text] [Related]
26. Prognostic Factors for Survival After Transarterial Chemoembolization Combined with Sorafenib in the Treatment of BCLC Stage B and C Hepatocellular Carcinomas.
Ni JY; Kong J; Sun HL; Chen YT; Luo JH; Wang WD; Chen D; Jiang XY; Xu LF
Acad Radiol; 2018 Apr; 25(4):423-429. PubMed ID: 29198946
[TBL] [Abstract][Full Text] [Related]
27. Comprehensive treatments for hepatocellular carcinoma with tumor thrombus in major portal vein.
Ye HH; Ye JZ; Xie ZB; Peng YC; Chen J; Ma L; Bai T; Chen JZ; Lu Z; Qin HG; Xiang BD; Li LQ
World J Gastroenterol; 2016 Apr; 22(13):3632-43. PubMed ID: 27053855
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of sorafenib in intermediate-stage hepatocellular carcinoma patients refractory to transarterial chemoembolization.
Ogasawara S; Chiba T; Ooka Y; Kanogawa N; Motoyama T; Suzuki E; Tawada A; Kanai F; Yoshikawa M; Yokosuka O
Oncology; 2014; 87(6):330-41. PubMed ID: 25227534
[TBL] [Abstract][Full Text] [Related]
29. Sorafenib With and Without Transarterial Chemoembolization for Advanced Hepatocellular Carcinoma With Main Portal Vein Tumor Thrombosis: A Retrospective Analysis.
Zhang Y; Fan W; Wang Y; Lu L; Fu S; Yang J; Huang Y; Yao W; Li J
Oncologist; 2015 Dec; 20(12):1417-24. PubMed ID: 26446238
[TBL] [Abstract][Full Text] [Related]
30. Combined hepatocellular-cholangiocarcinoma successfully treated with sorafenib: case report and review of the literature.
Futsukaichi Y; Tajiri K; Kobayashi S; Nagata K; Yasumura S; Takahara T; Minemura M; Yasuda I
Clin J Gastroenterol; 2019 Apr; 12(2):128-134. PubMed ID: 30374884
[TBL] [Abstract][Full Text] [Related]
31. [A Case of Peritoneal Dissemination of Hepatocellular Carcinoma after Laparoscopic Hepatectomy].
Takiuchi D; Morimoto O; Hokkoku D; Wada R; Ikeshima R; Munakata K; Wada N; Akamaru Y; Ota H; Shibata K; Ohashi H
Gan To Kagaku Ryoho; 2018 Dec; 45(13):2174-2176. PubMed ID: 30692322
[TBL] [Abstract][Full Text] [Related]
32. [Surgical Resection of the Lymph Node Metastasis after Liver Resection for Hepatocellular Carcinoma].
Hashimoto Y; Kishimoto T; Nagano S; Murotani M; Shigetsu K; Yoneda N; Morioka T; Kidogami S; Mokutani Y; Hirose H; Yoshioka S; Kawata J; Takeda M; Tamura S; Sasaki Y
Gan To Kagaku Ryoho; 2020 Dec; 47(13):2284-2286. PubMed ID: 33468935
[TBL] [Abstract][Full Text] [Related]
33. Sorafenib treatment has the potential to downstage advanced hepatocellular carcinoma before liver resection.
Bertacco A; Vitale A; Mescoli C; Cillo U
Per Med; 2020 Mar; 17(2):83-87. PubMed ID: 32157952
[TBL] [Abstract][Full Text] [Related]
34. The safety and efficacy of transarterial chemoembolization combined with sorafenib and sorafenib mono-therapy in patients with BCLC stage B/C hepatocellular carcinoma.
Wu FX; Chen J; Bai T; Zhu SL; Yang TB; Qi LN; Zou L; Li ZH; Ye JZ; Li LQ
BMC Cancer; 2017 Sep; 17(1):645. PubMed ID: 28899349
[TBL] [Abstract][Full Text] [Related]
35. [Clinical analysis of the treatment:transcatheter arterial chemoembolization combined with sorafenib in advanced hepatocellular carcinoma].
Li Y; Huang JW; Lu LG; Shao PJ; Hu BS; Huang GM; Wei ZG; Zhang L
Zhonghua Yi Xue Za Zhi; 2010 Aug; 90(31):2187-92. PubMed ID: 21029658
[TBL] [Abstract][Full Text] [Related]
36. [A Case of Wilson's Disease with Psoriasis Vulgaris, Complicated with Hepatocellular Carcinoma and Successfully Treated with Sorafenib].
Nakagawa T; Chubachi S
Gan To Kagaku Ryoho; 2015 Sep; 42(9):1107-9. PubMed ID: 26469170
[TBL] [Abstract][Full Text] [Related]
37. The combination of transcatheter arterial chemoembolization and sorafenib is well tolerated and effective in Asian patients with hepatocellular carcinoma: final results of the START trial.
Chao Y; Chung YH; Han G; Yoon JH; Yang J; Wang J; Shao GL; Kim BI; Lee TY
Int J Cancer; 2015 Mar; 136(6):1458-67. PubMed ID: 25099027
[TBL] [Abstract][Full Text] [Related]
38. Machine Learning Predictive Model to Guide Treatment Allocation for Recurrent Hepatocellular Carcinoma After Surgery.
Famularo S; Donadon M; Cipriani F; Fazio F; Ardito F; Iaria M; Perri P; Conci S; Dominioni T; Lai Q; La Barba G; Patauner S; Molfino S; Germani P; Zimmitti G; Pinotti E; Zanello M; Fumagalli L; Ferrari C; Romano M; Delvecchio A; Valsecchi MG; Antonucci A; Piscaglia F; Farinati F; Kawaguchi Y; Hasegawa K; Memeo R; Zanus G; Griseri G; Chiarelli M; Jovine E; Zago M; Abu Hilal M; Tarchi P; Baiocchi GL; Frena A; Ercolani G; Rossi M; Maestri M; Ruzzenente A; Grazi GL; Dalla Valle R; Romano F; Giuliante F; Ferrero A; Aldrighetti L; Bernasconi DP; Torzilli G;
JAMA Surg; 2023 Feb; 158(2):192-202. PubMed ID: 36576813
[TBL] [Abstract][Full Text] [Related]
39. Enhanced therapeutic efficacy of combined use of sorafenib and transcatheter arterial chemoembolization for treatment of advanced hepatocellular carcinoma.
Zhou L; Li J; Ai DL; Fu JL; Peng XM; Zhang LZ; Wang JY; Zhao Y; Yang B; Yu Q; Liu CZ; Wang HM
Jpn J Clin Oncol; 2014 Aug; 44(8):711-7. PubMed ID: 24855686
[TBL] [Abstract][Full Text] [Related]
40. [Combination Chemotherapy Using Sorafenib and Hepatic Arterial Infusion with a Fine-Powder Formulation of Cisplatin for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis--A Case Report].
Tsukamoto T; Kanazawa A; Shimizu S; Murata A; Sakae M; Kurihara S; Tashima T; Deguchi S; Nakai T; Kawasaki Y; Kioka K
Gan To Kagaku Ryoho; 2015 Nov; 42(12):1878-80. PubMed ID: 26805203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
